When leukemia relapses after chemotherapy, many patients and families fear their options have run out. The reality is more hopeful: advanced treatments including CAR-T cell therapy, stem cell transplants, and immunotherapies can deliver remission even after standard regimens fail. Key Takeaways Treatment options remain available when leukemia relapses after chemotherapy, CAR-T cell therapy is FDA-approved for B-cell ALL and CLL, while allogeneic stem cell transplant addresses

TL;DR Chemotherapy resistance develops through acquired mechanisms including genetic mutations, efflux pumps, and clonal evolution that allow cancer cells to survive treatment Dr. Bharat Patodiya provides advanced molecular profiling to identify specific resistance patterns and guide personalized treatment strategies Alternative therapies including CAR-T cell therapy, TIL therapy, and gene therapy offer hope for patients with chemotherapy-resistant blood cancers Early consult